Financial Advisor to IDD BioTech

Financial Advisor to IDD BioTech

  BACK Novistra Capital advises IDD Biotech on its license agreement with Enzene Biosciences, a subsidiary of Alkem Labs New Delhi, December 2019 Novistra Capital, a New York based boutique advisory, announced today that International Drug Development Biotech...
Buy-Side Advisor to ACN Healthcare

Buy-Side Advisor to ACN Healthcare

  BACK Novistra Capital advises ACN Healthcare on its merger with Rapid Care’s RCM business New York, November 2019 Novistra Capital, a New York based boutique M&A advisory, announced today that ACN Healthcare has merged with the revenue cycle management business...
Buy-Side Advisor to Hitech

Buy-Side Advisor to Hitech

  BACK Novistra Capital advises Hitech on acquiring a majority stake in Tekenplus London, July 2019 Novistra Capital is pleased to announce that Hitech has acquired a majority stake in Tekenplus. Hitech is an integrated engineering consulting and business process...
Buy-Side Advisor to Reed Exhibitions

Buy-Side Advisor to Reed Exhibitions

  BACK Novistra advises Reed Exhibition, a division of RELX Group, on its acquisition of India Big7 New Delhi, March 2019 Novistra Capital, a New York based boutique M&A advisory, is pleased to announce that Reed Exhibitions, a division of RELX Group, has...
Sell-Side Advisor to Pacific BPO

Sell-Side Advisor to Pacific BPO

  BACK Novistra Capital advises Pacific BPO on its sale to Access Healthcare New York, September 2018 Novistra Capital, a New York based boutique advisory, is pleased to announce that Pacific BPO Pvt. Ltd. has been acquired by Access Healthcare. Founded in 2010,...